2003
DOI: 10.1073/pnas.0237311100
|View full text |Cite
|
Sign up to set email alerts
|

A photochemical approach to the lipid accessibility of engineered cysteinyl residues

Abstract: Ordinary electrophilic reagents react too slowly in a nonpolar environment to be useful for the determination of the accessibility to lipid of continuous stretches of residues mutated to cysteine. By contrast, photoactivated 5-iodonaphthyl-1-azide (INA) reacted readily with 2-mercaptoethanol and dodecanethiol in nonpolar solvents and in liposomes. Continuous stretches of residues in the amphipathic N-terminal helix and first transmembrane helix of the bacterial potassium channel KcsA were replaced with cystein… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2019
2019

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…Reduction in the binding of INA-inactivated viruses with their respective antibodies has been described previously [17][18][19][20]22]. INA binds to the cysteine amino acid residues in proteins [24]. Although the lateral-ridge region of domain III (DIII) of ZIKV E-protein that binds with the ZV-54 antibody does not have a cysteine residue, there are two cysteine residues in this sequence that are present adjacent to the amino acid sequence that interacts with the antibody ZV-54 [25].…”
Section: Discussionmentioning
confidence: 99%
“…Reduction in the binding of INA-inactivated viruses with their respective antibodies has been described previously [17][18][19][20]22]. INA binds to the cysteine amino acid residues in proteins [24]. Although the lateral-ridge region of domain III (DIII) of ZIKV E-protein that binds with the ZV-54 antibody does not have a cysteine residue, there are two cysteine residues in this sequence that are present adjacent to the amino acid sequence that interacts with the antibody ZV-54 [25].…”
Section: Discussionmentioning
confidence: 99%